Live from the NIH registry
Studies recruiting near Mission Viejo right now
Top 25 of 1,380 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
University of California - Irvine — Irvine, California (10.5 mi)
· Sponsor: AskBio Inc
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Orange County — Orange, California (16.8 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
Marvel Clinical Research — Huntington Beach, California (20.1 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (18.5 mi)
· Sponsor: Takeda
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Orange County Retina Med Group — Santa Ana, California (15.4 mi)
· Sponsor: Genentech, Inc.
YAG Laser Vitreolysis for Vitreous Floaters
Posterior Vitreous Detachment, Myopic Vitreopathy
N/A
Interventional 50 participants sought
VMR Institute for Vitreous Macula Retina — Huntington Beach, California (20.1 mi)
· Sponsor: VMR Consulting, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Irvine, California (10.5 mi)
· Sponsor: AstraZeneca
Gen 2 Battrode Wear Study
Adhesive Wear Time
N/A
Interventional 30 participants sought
Orange County Research Center — Lake Forest, California (3.2 mi)
· Sponsor: Baxter Healthcare Corporation
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (15.8 mi)
· Sponsor: Guardant Health, Inc.
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
University of California Irvine — Orange, California (16.8 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine — Irvine, California (10.5 mi)
· Sponsor: Eli Lilly and Company
Effect of Electro-Acupuncture on Blood Pressure
Hypertension
N/A
Interventional 160 participants sought
Susan Samueli Integrative Health Institute — Irvine, California (10.5 mi)
· Sponsor: University of California, Irvine
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
City of Hope at Irvine Lennar — Irvine, California (10.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
Hoag Hospital Newport Beach — Newport Beach, California (15.8 mi)
· Sponsor: Takeda
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
UC Irvine Medical Center, — Orange, California (16.8 mi)
· Sponsor: Joseph Broderick, MD
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
Glaucoma, Ocular Surface Disease
N/A
Observational 75 participants sought
Doheny Eye Center UCLA — Fountain Valley, California (18.5 mi)
· Sponsor: University of California, Los Angeles
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Univ Cali Irvine ALS Neuromuscular — Orange, California (16.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Advanced Research Center /ID# 270257 — Anaheim, California (21.6 mi)
· Sponsor: AbbVie
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Radin Cardiovascular Medical Group, Inc — Newport Beach, California (15.8 mi)
· Sponsor: Duke University
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Colorectal Cancer Metastatic
Phase 2
Interventional 20 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (15.8 mi)
· Sponsor: Buzzard Pharmaceuticals
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California (10.5 mi)
· Sponsor: NRG Oncology
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
UCLA Hematology/Oncology - Laguna Hills — Laguna Hills, California (3.3 mi)
· Sponsor: Pfizer
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
Cancer, Neoplasms
N/A
Interventional 35 participants sought
Chao Family Comprehensive Cancer Center and Ambulatory Care building — Irvine, California (10.5 mi)
· Sponsor: University of California, Irvine
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Children's Hospital of Orange County — Orange, California (16.8 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
UCI Health-UCI Medical Center — Orange, California (16.8 mi)
· Sponsor: Calliditas Therapeutics AB